Integrative analysis of loss-of-function variants in clinical and genomic data reveals novel genes associated with cardiovascular traits

被引：0

作者：

Benjamin S. Glicksberg

Letizia Amadori

Nicholas K. Akers

Katyayani Sukhavasi

Oscar Franzén

Li Li

Gillian M. Belbin

Kristin L. Akers

Khader Shameer

Marcus A. Badgeley

Kipp W. Johnson

Ben Readhead

Bruce J. Darrow

Eimear E. Kenny

Christer Betsholtz

Raili Ermel

Josefin Skogsberg

Arno Ruusalepp

Eric E. Schadt

Joel T. Dudley

Hongxia Ren

Jason C. Kovacic

Chiara Giannarelli

Shuyu D. Li

Johan L. M. Björkegren

Rong Chen

机构：

[1] Icahn School of Medicine at Mount Sinai,Department of Genetics and Genomic Sciences, The Icahn Institute for Genomics and Multiscale Biology

[2] Icahn School of Medicine at Mount Sinai,The Institute for Next Generation Healthcare

[3] Cardiovascular Research Center and Cardiovascular Institute,Department of Pathophysiology, Institute of Biomedicine and Translation Medicine

[4] Icahn School of Medicine at Mount Sinai,Department of Cardiac Surgery

[5] University of Tartu,Integrated Cardio Metabolic Centre, Department of Medicine, Karolinska Institutet

[6] Biomeedikum,Department of Pediatrics, Herman B Wells Center for Pediatric Research, Center for Diabetes and Metabolic Diseases, Stark Neurosciences Research Institute

[7] Clinical Gene Networks AB,Bakar Computational Health Sciences Institute

[8] Charles Bronfman Institute of Personalized Medicine,undefined

[9] Icahn School of Medicine at Mount Sinai,undefined

[10] Sema4,undefined

[11] a Mount Sinai venture,undefined

[12] Department of Preventive Medicine,undefined

[13] Icahn School of Medicine at Mount Sinai,undefined

[14] Department of Immunology,undefined

[15] Genetics and Pathology,undefined

[16] Tartu University Hospital,undefined

[17] Karolinska Universitetssjukhuset Huddinge,undefined

[18] Department of Health Policy and Research,undefined

[19] Icahn School of Medicine at Mount Sinai,undefined

[20] Indiana University,undefined

[21] University of California San Francisco,undefined

[22] Integrated Cardio Metabolic Centre,undefined

[23] Department of Medicine,undefined

[24] Karolinska Institutet,undefined

[25] Novum,undefined

来源：

BMC Medical Genomics | / 12卷

关键词：

Loss-of-function variant; Cardiovascular traits; Genetic association; Integrative data analysis; Target identification and validation; Electronic Medical Records;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 384 条

[41]

Baigent C(2000)Triglyceride synthesis: insights from the cloning of diacylglycerol acyltransferase Curr Opin Lipidol 11 229-371

[42]

Keech A(2013)Pharmacological inhibition of diacylglycerol acyltransferase 1 reduces body weight and modulates gut peptide release--potential insight into mechanism of action Obesity (Silver Spring, Md) 21 1406-412

[43]

Kearney PM(2013)Pharmacological inhibition to examine the role of DGAT1 in dietary lipid absorption in rodents and humans Am J Physiol Gastrointest Liver Physiol 304 G958-1102

[44]

Blackwell L(2007)Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance J Biol Chem 282 22678-163

[45]

Buck G(2008)Knockdown of acyl-CoA:diacylglycerol acyltransferase 2 with antisense oligonucleotide reduces VLDL TG and ApoB secretion in mice Biochim Biophys Acta 1781 97-41

[46]

Pollicino C(2005)Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice Hepatology (Baltimore, Md). 42 362-1705

[47]

Nelson MR(2011)Discovery of PF-04620110, a potent, selective, and orally bioavailable inhibitor of DGAT-1 ACS Med Chem Lett 2 407-181

[48]

Tipney H(2012)Drug discovery in pharmaceutical industry: productivity challenges and trends Drug Discov Today 17 1088-90

[49]

Painter JL(2011)Reasons for participating and genetic information needs among racially and ethnically diverse biobank participants: a focus group study J Community Genet 2 153-11776

[50]

Shen J(2014)Loss-of-function mutations in APOC3 and risk of ischemic vascular disease N Engl J Med 371 32-9825

← 1 2 3 4 5 6 7 8 9 10 →